Rocket Pharmaceuticals

+$1.32 (+12.89%) Today
+$0.29 (+2.51%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms.

CEO
Gaurav D. Shah
Employees
151
Headquarters
Cranbury, New Jersey
Founded
1999

RCKT Key Statistics

Market cap
761.09M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.11M
High today
$11.60
Low today
$9.87
Open price
$10.31
Volume
873.27K
52 Week high
$49.66
52 Week low
$7.57

RCKT News

Simply Wall St17h

Insiders who purchased Rocket Pharmaceuticals, Inc. stock last year recover some losses which currently stand at US$127k - Simply Wall St

Insiders who purchased US$382k worth of Rocket Pharmaceuticals, Inc. ( ) shares over the past year recouped some of their losses after price gained 8.0% last we

RCKT Earnings

-$1.08
-$0.72
-$0.36
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure